Drug Profile
Diphtheria tetanus vaccine - Celltech
Alternative Names: DT vaccine - CelltechLatest Information Update: 21 Sep 2007
Price :
$50
*
At a glance
- Originator Celltech R&D
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diphtheria; Tetanus
Most Recent Events
- 01 Mar 2000 Phase-III clinical trials for Diphtheria in USA (Unknown route)
- 01 Mar 2000 Phase-III clinical trials for Tetanus in USA (Unknown route)
- 02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group